This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Mithra Pharmaceuticals 관리
관리 기준 확인 1/4
현재 CEO에 대한 정보가 충분하지 않습니다.
주요 정보
Christophe Marechal
최고 경영자
n/a
총 보상
| CEO 급여 비율 | n/a |
| CEO 임기 | 7.6yrs |
| CEO 소유권 | n/a |
| 경영진 평균 재임 기간 | 4.4yrs |
| 이사회 평균 재임 기간 | 2.8yrs |
최근 관리 업데이트
Recent updates
Not Many Are Piling Into Mithra Pharmaceuticals SA (EBR:MITRA) Stock Yet As It Plummets 26%
Apr 06
Revenues Working Against Mithra Pharmaceuticals SA's (EBR:MITRA) Share Price Following 39% Dive
Feb 07Party Time: Brokers Just Made Major Increases To Their Mithra Pharmaceuticals SA (EBR:MITRA) Earnings Forecasts
Nov 09These Analysts Just Made A Huge Downgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) EPS Forecasts
Oct 05Take Care Before Diving Into The Deep End On Mithra Pharmaceuticals SA (EBR:MITRA)
May 23Bullish: Analysts Just Made A Huge Upgrade To Their Mithra Pharmaceuticals SA (EBR:MITRA) Forecasts
Aug 11Growth Investors: Industry Analysts Just Upgraded Their Mithra Pharmaceuticals SA (EBR:MITRA) Revenue Forecasts By 21%
Mar 13Mithra Pharmaceuticals (EBR:MITRA) Is Making Moderate Use Of Debt
Dec 22Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 24Here's Why Mithra Pharmaceuticals (EBR:MITRA) Can Afford Some Debt
Jun 07When Will Mithra Pharmaceuticals SA (EBR:MITRA) Turn A Profit?
May 10Is Mithra Pharmaceuticals SA's (EBR:MITRA) Shareholder Ownership Skewed Towards Insiders?
Mar 18We're Not So Sure You Should Rely on Mithra Pharmaceuticals' (EBR:MITRA) Statutory Earnings
Feb 16Analysts Expect Breakeven For Mithra Pharmaceuticals SA (EBR:MITRA) Before Long
Jan 21
Some Mithra Pharmaceuticals SA (EBR:MITRA) Analysts Just Made A Major Cut To Next Year's Estimates
Nov 29CEO
Christophe Marechal
7.6yrs
테뉴어
Mr. Christophe Maréchal has been the Chief Financial Officer of Mithra Pharmaceuticals SA since February 23, 2017 and also serves as its Co-Chief Executive Officer since March 5, 2024. Mr. Maréchal serves...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-CEO & CFO | 7.6yrs | 데이터 없음 | 데이터 없음 | |
| COO & Co-CEO | less than a year | 데이터 없음 | 데이터 없음 | |
| Chief Scientific Officer | 5.2yrs | 데이터 없음 | 데이터 없음 | |
| Head of Investor Relations | no data | 데이터 없음 | 데이터 없음 | |
| Secretary of the Board & General Counsel | no data | 데이터 없음 | 데이터 없음 | |
| Compliance Officer | no data | 데이터 없음 | 데이터 없음 | |
| Communication Director | no data | 데이터 없음 | 데이터 없음 | |
| HR Director | no data | 데이터 없음 | 데이터 없음 | |
| Chief Business Officer | 3.7yrs | 데이터 없음 | 0.000040% € 4.9 | |
| President of the Scientific Advisory Board & Executive Director | no data | €7.12k | 0.029% € 3.6k | |
| Head of Global Regulatory Affairs | no data | 데이터 없음 | 데이터 없음 | |
| Head of Program & Project Management | no data | 데이터 없음 | 데이터 없음 |
4.4yrs
평균 재임 기간
경험이 풍부한 관리: MITRA 의 관리팀은 경험 ( 4.4 년 평균 재직 기간)으로 간주됩니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| President of the Scientific Advisory Board & Executive Director | 8yrs | €7.12k | 0.029% € 3.6k | |
| Independent & Non-Executive Director | 1.7yrs | €25.00k | 데이터 없음 | |
| Non-Executive Director | 2.8yrs | €20.00k | 0.042% € 5.1k |
2.8yrs
평균 재임 기간
경험이 풍부한 이사회: MITRA 의 이사회는 경험(평균 재직 기간 2.8 년)으로 간주되지 않으므로 새 이사회가 필요합니다.